Patent: 8,071,532
Summary for Patent: 8,071,532
| Title: | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury |
| Abstract: | The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke. |
| Inventor(s): | Maurice Mannesse, Johannes Henricus Nuijens, Frank Pieper, Maria Grazia De Simoni, Gijsbertus Johannes Ziere |
| Assignee: | Pharming Intellectual Property BV |
| Application Number: | US12/158,987 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,071,532
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Pharming Americas Bv | RUCONEST | c1 esterase inhibitor (recombinant) | For Injection | 125495 | July 16, 2014 | 8,071,532 | 2026-12-19 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,071,532
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | E516043 | ⤷ Start Trial |
| Australia | 2006327989 | ⤷ Start Trial |
| Canada | 2632400 | ⤷ Start Trial |
| China | 101365478 | ⤷ Start Trial |
| China | 105641688 | ⤷ Start Trial |
| Cyprus | 1112452 | ⤷ Start Trial |
| Cyprus | 1119818 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
